Evidence map›Paper›PMID 36415218›Full record

ReviewLancet regional health. Americas2022

Canada has an opportunity to address antimicrobial resistance through COVID-19 recovery spending.

Deborah S Somanader, Ian Brunskill, Maureen Perrin, Herman Wildrik Barkema, Sean Hillier, Suzanne Hindmarch, J Scott Weese, Gerard D Wright, Andrew M Morris

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Lancet regional health. Americas, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Deborah S SomanaderAntimicrobial Stewardship Program, Sinai Health-University Health Network, Toronto, ON, Canada.
Ian BrunskillIgneum Inc., Toronto, ON, Canada.
Maureen PerrinSentient Meat Consulting, Ottawa, ON, Canada.
Herman Wildrik BarkemaOne Health at UCalgary, University of Calgary, Calgary, AB, Canada.
Sean HillierFaculty of Health, York University, Toronto, ON, Canada.
Suzanne HindmarchDepartment of Political Science, University of New Brunswick, Fredericton, NB, Canada.
J Scott WeeseOntario Veterinary College, University of Guelph, Guelph, ON, Canada.
Gerard D WrightMichael G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, ON, Canada.
Andrew M MorrisAntimicrobial Stewardship Program, Sinai Health-University Health Network, Toronto, ON, Canada.
University Health Network · CAMcMaster University · CAUniversity of Calgary · CAUniversity of Guelph · CAUniversity of New Brunswick · CAYork University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial Resistance (AMR) causes more than a million deaths globally per year due to infections incurable with currently available antibiotics. Failing to effectively address AMR will have significant negative consequences for Canadians and the Canadian economy. Canada is behind on allocation of required funding and nationally coordinated AMR mitigation strategies relative to other high-income countries. A Pan-Canadian AMR action plan and development of a new governance model is pending. Recent AMR-specific funding commitments are significant but fall short while distribution of funds indicate a siloed approach. Canada could initiate progress towards AMR mitigation through incorporation within the scope of budget allocations intended for COVID-19 recovery and mitigation efforts. We discuss the following components for inclusion: development of infectious disease diagnostics and therapeutics; antimicrobial stewardship interventions in long-term care and Indigenous communities; environmental monitoring of AMR; comprehensive antimicrobial use, and AMR surveillance; and support for capacity-building in low and middle-income countries.

Indexed as

Antibiotic developmentAntimicrobial resistanceAntimicrobial stewardshipCanadaFederal budgetFederalismGovernanceResistant bacteriaSurveillance

Identifiers

PMID36415218
PMCPMC9672386
OpenAlexW4309478758

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.